Insights into the mode of action of chitosan as an antibacterial compound

Applied and Environmental Microbiology

Volumn 74, Issue 12, 2008, Pages 3764-3773

  Raafat, Dina ^a   Von Bargen, Kristine ^a   Haas, Albert ^a   Sahl, Hans Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOCHEMICAL ENGINEERING; BIOCHEMISTRY; BIOMATERIALS; CELL MEMBRANES; CHITIN; CHITOSAN; ELECTRON MICROSCOPY; ELECTRON OPTICS; EXTRACTION; GENES; HEALTH; IMAGING TECHNIQUES; LIPIDS; MEMBRANES; METABOLISM; MICROSCOPIC EXAMINATION; POLYMERS; POLYSACCHARIDES; SOLVENT EXTRACTION; TELLURIUM COMPOUNDS; TISSUE; WALLS (STRUCTURAL PARTITIONS);

(ABIOTIC AND BIOTIC) STRESS; AMERICAN SOCIETY; ANTI MICROBIAL ACTIVITIES; ANTIMICROBIAL ACTION; BACTERIAL DEATH; BIOLOGICAL CHARACTERISTICS; CELL WALL BIOSYNTHESIS; CELL WALLS; CELLULAR COMPONENTS; CHITOSAN TREATMENT; DOSE DEPENDENT; ENERGY METABOLISM; EXPRESSION PROFILING; IN-VITRO ASSAYS; INHIBITORY EFFECTS; LEAKAGE MEASUREMENTS; MEMBRANE DEPOLARIZATION; MEMBRANE LIPIDS; MEMBRANE POTENTIALS; MODE OF ACTION; PERMEABILIZATION; SEQUENCE OF EVENTS; STAPHYLOCOCCUS AUREUS (SA); TEICHOIC ACIDS; TRANSCRIPTIONAL RESPONSES; WIDE-RANGE;

AMINES;

BIOPOLYMER; CHITOSAN; LIPOTEICHOIC ACID; MEMBRANE LIPID; POLYSACCHARIDE; TEICHOIC ACID;

ANTIMICROBIAL ACTIVITY; BACTERIUM; CHITIN; CYTOLOGY; GENE EXPRESSION; METABOLISM; PHYSICOCHEMICAL PROPERTY;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CELL PERMEABILIZATION; CULTURE MEDIUM; CYTOLYSIS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENE FUNCTION; GROWTH INHIBITION; MEASUREMENT; NONHUMAN; STRESS;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CELL WALL; CHITOSAN; COLONY COUNT, MICROBIAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; MEMBRANE POTENTIALS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, TRANSMISSION; PERMEABILITY; POTASSIUM; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SIMULANS;

EID: 45749108316     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.00453-08     Document Type: Article

References (54)

1. Babel, S., and T. A. Kurniawan. 2003. Low-cost adsorbents for heavy metals uptake from contaminated water: a review. J. Hazard. Mater. 97:219-243.
2. Baumert, N., C. von Eiff, F. Schaaff, G. Peters, R. A. Proctor, and H.-G. Sahl. 2002. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb. Drug Resist. 8:253-260.
3. Bhatia, S. C., and N. Ravi. 2003. A Mössbauer study of the interaction of chitosan and D-glucosamine with iron and its relevance to other metalloenzymes. Biomacromolecules 4:723-727.
4. Bierbaum, G., and H. G. Sahl. 1987. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J. Bacteriol. 169:5452-5458.
5. Bonelli, R. R., T. Schneider, H.-G. Sahl, and I. Wiedemann. 2006. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 50:1449-1457.
6. Bore, E., S. Langsrud, Ø. Langsrud, T. M. Rode, and A. Holck. 2007. Acid-shock responses in Staphylococcus aureus investigated by global gene expression analysis. Microbiology 153:2289-2303.
7. Bowman, K., and K. W. Leong. 2006. Chitosan nanoparticles for oral drug and gene delivery. Int. J. Nanomedicine 1:117-128.
8. Chang, W., D. A. Small, F. Toghrol, and W. E. Bentley. 2006. Global transcriptome analysis of Staphylococcus aureus response to hydrogen peroxide. J. Bacteriol. 188:1648-1659.
9. Chirkov, S. N. 2002. The antiviral activity of chitosan. Appl. Biochem. Microbiol. 38:1-8. (In Russian.)
10. Didenko, L. V., D. V. Gerasimenko, N. D. Konstantinova, T. A. Silkina, I. D. Avdienko, G. E. Bannikova, and V. P. Varlamov. 2005. Ultrastructural study of chitosan effects on Klebsiella and staphylococci. Bull. Exp. Biol. Med. 140:356-360.
11. Dmitriev, B. A., F. V. Toukach, O. Holst, E. T. Rietschel, and S. Ehlers. 2004. Tertiary structure of Staphylococcus aureus cell wall murein. J. Bacteriol. 186:7141-7148.
12. Doares, S. H., T. Syrovets, E. W. Weiler, and C. A. Ryan. 1995. Oligogalacturonides and chitosan activate plant defensive genes through the octadecanoid pathway. Proc. Natl. Acad. Sci. USA 92:4095-4098.
13. Dodane, V., and V. D. Vilivalam. 1998. Pharmaceutical applications of chitosan. Pharm. Sci. Technol. Today 1:246-253.
14. Fedtke, I., D. Mader, T. Kohler, H. Moll, G. Nicholson, R. Biswas, K. Henseler, F. Götz, U. Zähringer, and A. Peschel. 2007. A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol. Microbiol. 65:1078-1091.
15. Fischer, W. 1994. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med. Microbiol. Immunol. 183:61-76.
16. Fisher, J. F., S. O. Meroueh, and S. Mobashery. 2006. Nanomolecular and supramolecular paths toward peptidoglycan structure. Microbe 1:420-427.
17. Fuchs, S., J. Pané-Farré, C. Kohler, M. Hecker, and S. Engelmann. 2007. Anaerobic gene expression in Staphylococcus aureus. J. Bacteriol. 189:4275-4289.
18. Groicher, K. H., B. A. Firek, D. F. Fujimoto, and K. W. Bayles. 2000. The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance. J. Bacteriol. 182:1794-1801.
19. Helander, I. M., E.-L. Nurmiaho-Lassila, R. Ahvenainen, J. Rhoades, and S. Roller. 2001. Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. Int. J. Food Microbiol. 71:235-244.
20. Illum, L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1326-1331.
21. Je, J.-Y., and S.-K. Kim. 2006. Chitosan derivatives killed bacteria by disrupting the outer and inner membrane. J. Agric. Food Chem. 54:6629-6633.
22. Kohler, C., C. von Eiff, G. Peters, R. A. Proctor, M. Hecker, and S. Engelmann. 2003. Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach. J. Bacteriol. 185:6928-6937.
23. Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Q. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
25. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
26. Lührmann, A., and A. Haas. 2000. A method to purify bacteria-containing phagosomes from infected macrophages. Methods Cell Sci. 22:329-341.
27. McAleese, F., S. W. Wu, K. Sieradzki, P. Dunman, E. Murphy, S. Projan, and A. Tomasz. 2006. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin. J. Bacteriol. 188:1120-1133.
28. Muzzarelli, R., R. Tarsi, O. Filippini, E. Giovanetti, G. Biagini, and P. E. Varaldo. 1990. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob. Agents Chemother. 34:2019-2023.
29. O'Byrne, C. P., and I. R. Booth. 2002. Osmoregulation and its importance to food-borne microorganisms. Int. J. Food Microbiol. 74:203-216.
30. Orlov, D. S., T. Nguyen, and R. I. Lehrer. 2002. Potassium release, a useful tool for studying antimicrobial peptides. J. Microbiol. Methods 49:325-328.
31. Pag, U., M. Oedenkoven, V. Sass, Y. Shai, O. Shamova, N. Antcheva, A. Tossi, and H.-G. Sahl. 2008. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an α-helical 'sequence template'. J. Antimicrob. Chemother. 61:341-352.
32. Peschel, A., M. Otto, R. W. Jack, H. Kalbacher, G. Jung, and F. Götz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
33. Peter, M. G. 1997. Introductory remarks. Carb. Eur. 19:9-15.
34. Proctor, R. A., C. von Eiff, B. C. Kahl, K. Becker, P. McNamara, M. Herrmann, and G. Peters. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4:295-305.
35. Rabea, E. I., M. E.-T. Badawy, C. V. Stevens, G. Smagghe, and W. Steurbaut. 2003. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 4:1457-1465.
36. Rhoades, J., and S. Roller. 2000. Antimicrobial actions of degraded and native chitosan against spoilage organisms in laboratory media and foods. Appl. Environ. Microbiol. 66:80-86.
37. Rouget, M. C. 1859. Des substances amylacées dans les tissus des animaux, spécialement des Articulés (chitine). Comp. Rend. 48:792-795.
38. Ruhr, E., and H.-G. Sahl. 1985. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother. 27:841-845.
39. Sahl, H.-G., U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi. 2005. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77:466-475.
40. Sass, V., U. Pag, A. Tossi, G. Bierbaum, and H.-G. Sahl. Mode of action of human β-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int. J. Med. Microbiol. doi:10.1016/j.ijmm.2008.01.011.
41. Singla, A. K., and M. Chawla. 2001. Chitosan: some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 53:1047-1067.
42. Takai, K., T. Ohtsuka, Y. Senda, M. Nakao, K. Yamamoto, J. Matsuoka, and Y. Hirai. 2002. Antibacterial properties of antimicrobial-finished textile products. Microbiol. Immunol. 46:75-81.
43. Tharanathan, R. N., and F. S. Kittur. 2003. Chitin - the undisputed biomolecule of great potential. Crit. Rev. Food Sci. Nutr. 43:61-87.
44. Ueno, H., T. Mori, and T. Fujinaga. 2001. Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 52:105-115.
45. Utaida, S., P. M. Dunman, D. Macapagal, E. Murphy, S. J. Projan, V. K. Singh, R. K. Jayaswal, and B. J. Wilkinson. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732.
46. van de Rijn, I., and R. E. Kessler. 1980. Growth characteristics of group A streptococci in a new chemically defined medium. Infect. Immun. 27:444-448.
47. Vollmer, W., and J. V. Holtje. 2004. The architecture of the murein (peptidoglycan) in gram-negative bacteria: vertical scaffold or horizontal layer(s)? J. Bacteriol. 186:5978-5987.
48. Weidenmaier, C., J. F. Kokai-Kun, S. A. Kristian, T. Chanturiya, H. Kalbacher, M. Gross, G. Nicholson, B. Neumeister, J. J. Mond, and A. Peschel. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10:243-245.
49. Weinrick, B., P. M. Dunman, F. McAleese, E. Murphy, S. J. Projan, Y. Fang, and R. P. Novick. 2004. Effect of mild acid on gene expression in Staphylococcus aureus. J. Bacteriol. 186:8407-8423.
50. Wiedemann, I., R. Benz, and H.-G. Sahl. 2004. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J. Bacteriol. 186:3259-3261.
51. Wiedemann, I., E. Breukink, C. van Kraaij, O. P. Kuipers, G. Bierbaum, B. de Kruijff, and H.-G. Sahl. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276:1772-1779.
52. Wydro, P., B. Krajewska, and K. Hac-Wydro. 2007. Chitosan as a lipid binder: a Langmuir monolayer study of chitosan-lipid interactions. Biomacromolecules 8:2611-2617.
53. Ylitalo, R., S. Lehtinen, E. Wuolijoki, P. Ylitalo, and T. Lehtimäki. 2002. Cholesterol-lowering properties and safety of chitosan. Arzneimittelforschung 52:1-7. (In German.)
54. Zakrzewska, A., A. Boorsma, S. Brul, K. J. Hellingwerf, and F. M. Klis. 2005. Transcriptional response of Saccharomyces cerevisiae to the plasma membrane-perturbing compound chitosan. Eukaryot. Cell 4:703-715.